Name | 3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, hydrochloride (1:1), (3R,4R)- |
---|---|
Synonyms |
PPDA-001 HCL SALT
CT7001 hydrochloride |
Description | CT7001 hydrochloride is a selective CDK7 inhibitor, with IC50s of 41 nM and 578 nM for CDK7/CycH/MAT1 and CDK2/cycE1, respectively. |
---|---|
Related Catalog | |
Target |
CDK7/CycH/MAT1:41 nM (IC50) CDK2/cycE1:578 nM (IC50) |
In Vitro | CT7001 (ICEC0942) is a selective CDK7 inhibitor, with IC50s of 41 nM and 578 nM for CDK7/CycH/MAT1 and CDK2/cycE1, respectively[1]. |
Kinase Assay | The purified recombinant CDK2/cycE1 and CDK7/CycH/MAT1 are used in the assay. Kinase assays are performed. Briefly, Rb-CTF and RNA Polymerase II peptide is used for CDK2 and CDK7 kinase assays, respectively. A luciferase assay is used to determine ATP remaining at the end of the kinase reaction, which provides a measure of kinase activity. GraphPad Prism Software is used to generate the IC50 values for each CDK[1]. |
References |
Molecular Formula | C22H31ClN6O |
---|---|
Molecular Weight | 430.97 |
Storage condition | 2-8℃ |